1. Home
  2. ACR vs CRBP Comparison

ACR vs CRBP Comparison

Compare ACR & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$19.01

Market Cap

134.4M

Sector

Real Estate

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$10.14

Market Cap

147.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACR
CRBP
Founded
2005
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.4M
147.4M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
ACR
CRBP
Price
$19.01
$10.14
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$24.50
$45.60
AVG Volume (30 Days)
16.0K
204.6K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$100.00
P/E Ratio
$19.59
N/A
Revenue Growth
N/A
97.62
52 Week Low
$16.51
$5.12
52 Week High
$24.61
$20.56

Technical Indicators

Market Signals
Indicator
ACR
CRBP
Relative Strength Index (RSI) 46.65 61.56
Support Level $18.73 $9.86
Resistance Level $18.98 $11.64
Average True Range (ATR) 0.39 0.67
MACD 0.00 0.11
Stochastic Oscillator 20.60 77.19

Price Performance

Historical Comparison
ACR
CRBP

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: